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Available online 18 December 2015Aberrant brain iron deposition is observed in both common and rare neurodegenerative disorders, including
those categorized as Neurodegeneration with Brain Iron Accumulation (NBIA), which are characterized by
focal iron accumulation in the basal ganglia. TwoNBIA genes are directly involved in ironmetabolism, butwheth-
er other NBIA-related genes also regulate iron homeostasis in the human brain, andwhether aberrant iron depo-
sition contributes to neurodegenerative processes remains largely unknown. This study aims to expand our
understanding of these iron overload diseases and identify relationships between known NBIA genes and their
main interacting partners by using a systems biology approach.
We used whole-transcriptome gene expression data from human brain samples originating from 101
neuropathologically normal individuals (10 brain regions) to generate weighted gene co-expression networks
and cluster the 10 known NBIA genes in an unsupervised manner. We investigated NBIA-enriched networks
for relevant cell types and pathways, and whether they are disrupted by iron loading in NBIA diseased tissue
and in an in vivo mouse model.
We identiﬁed two basal ganglia gene co-expressionmodules signiﬁcantly enriched for NBIA genes,which resem-
ble neuronal and oligodendrocytic signatures. TheseNBIA genenetworks are enriched for iron-related genes, and
implicate synapse and lipid metabolism related pathways. Our data also indicates that these networks are
disrupted by excessive brain iron loading.
We identiﬁed multiple cell types in the origin of NBIA disorders. We also found unforeseen links between NBIA
networks and iron-related processes, and demonstrate convergent pathways connecting NBIAs and phenotypi-
cally overlapping diseases. Our results are of further relevance for these diseases by providing candidates for
new causative genes and possible points for therapeutic intervention.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
Human brain
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WGCNA
NBIA
Iron metabolism1. Introduction
Aberrant brain iron deposition occurs in common neurodegenera-
tive disorders (e.g. Parkinson's and Alzheimer's diseases (Oakley et al.,Neuroscience, UCL Institute of
rt).
ect.com).
. This is an open access article under2007; Tao et al., 2014)), and more prominently in rare inherited dis-
eases categorized as Neurodegeneration with Brain Iron Accumulation
(NBIA) (Dusek et al., 2012). Iron is essential for normal brain function
and is heterogeneously and dynamically distributed in the brain
(Piñero and Connor, 2000; Rouault, 2013). The basal ganglia are
among the regions with highest iron levels, and the highest concentra-
tions are observed in oligodendrocytes. Our understanding of brain iron
metabolism and how it relates to neurodegeneration and disease is lim-
ited due to the inability to distinguish brain cell types via non-invasive
techniques (e.g. MRI) and poor understanding of how iron trafﬁcs inthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
60 C. Bettencourt et al. / Neurobiology of Disease 87 (2016) 59–68the brain to adequately supply neurons, astrocytes, oligodendrocytes
and microglia (Rouault, 2013; Kruer et al., 2012; Schneider et al.,
2013; Levi and Finazzi, 2014).
NBIA disorders are clinically characterized by a progressive move-
ment disorder with complicating symptoms that can vary signiﬁcantly
in terms of range and severity, and frequently include neuropsychiatric
disturbances, such as cognitive deﬁcits, personality changes with impul-
sivity and violent outbursts, depression, emotional lability, and obsessive
compulsive disorder (Gregory et al., 2009). This clinically heterogeneous
picture is uniﬁed by focal brain iron accumulation, predominantly in the
basal ganglia (Kruer et al., 2012; Schneider et al., 2013; Levi and Finazzi,
2014). Ten NBIA genetic diseases have already been deﬁned (Table 1),
yet many cases remain genetically undiagnosed (Levi and Finazzi,
2014). Two NBIA genes (FTL and CP) are directly involved in iron metab-
olism, but it remains elusivewhether otherNBIA genes also regulate iron-
related processes in the human brain.
We analyzed whole-transcriptome gene expression data from nor-
mal human brain and usedweighted gene co-expression network anal-
ysis (WGCNA) to group NBIA genes into modules in an unsupervised
manner (Langfelder and Horvath, 2008; Oldham et al., 2006, 2008;
Zhang and Horvath, 2005). This systems-biology approach (Lee et al.,
2004; Stuart et al., 2003) enables the identiﬁcation ofmodules of biolog-
ically related genes that are co-expressed and co-regulated (Oldham
et al., 2008; Konopka, 2011; Rosen et al., 2011; Winden et al., 2009),
and can give insights on cell-speciﬁc molecular signatures (Oldham
et al., 2008; Bettencourt et al., 2014; Forabosco et al., 2013). The main
goal of this study was to expand our understanding of these iron
overload diseases by identifying relationships and shared molecular
pathways between known NBIA genes, and unraveling transcrip-
tionally linked novel candidates to facilitate discovery of new
genes associated with these diseases and of possible entry points
to therapeutic intervention.
2. Subjects and methods
2.1. Human control brain samples and whole-genome expression proﬁling
Brain samples from 101 adult individuals were collected by the
Medical Research Council (MRC) Sudden Death Brain and Tissue Bank
(Millar et al., 2007). All brains samples were neuropathologically nor-
mal, had fully informed consent and were authorized for ethically ap-
proved scientiﬁc investigation (Research Ethics Committee 10/H0716/
3). Within the frame of the UK Brain Expression Consortium (UKBEC),
total RNA was isolated and processed for analysis using Affymetrix
Exon 1.0 ST Arrays (Affymetrix UK Ltd., High Wycombe, UK) as de-
scribed elsewhere (Bettencourt et al., 2014; Forabosco et al., 2013;
Trabzuni et al., 2011).
2.2. Weighted gene co-expression network analysis in the adult normal hu-
man brain
Using whole-transcriptome gene expression data, NBIA genes/tran-
scripts were assigned to co-expression modules (arbitrary colors) iden-
tiﬁed through WGCNA (Langfelder and Horvath, 2008; Zhang and
Horvath, 2005). For the adult brain network analysis (10 brain regions
from 101 adult individuals, UKBEC data) a total of 15,409 transcripts
(13,706 genes) passing quality control were used to identify modules,
and 3743 additional transcripts (3541 genes)were assigned tomodules
based on their highest module membership, as previously described
(Forabosco et al., 2013). Brieﬂy, the WGCNA network was constructed
for each tissue using a signed network with power (Beta) of 12 to
achieve a scale-free topology. A dissimilarity matrix based on topologi-
cal overlap measure (TOM) was used to identify gene modules (i.e.
densely interconnected and co-expressed genes), through a dynamic
tree-cutting algorithm. More details are given by Forabosco et al.
(2013).Module preservation statistics (Z summary) were calculated as pre-
viously described (Langfelder et al., 2011) to assess how well modules
from one tissue are preserved in another tissue. Based on the empirical
thresholds proposed by Langfelder et al. (Langfelder et al., 2011), Z sum-
mary scores above 10 indicate strong evidence for module preservation
across brain regions. To determine the relevance of each gene in a
module, we estimated the module membership (MM), also known as
eigengene-based connectivity. Gene interconnections within NBIA
transcript-enriched modules were further investigated using VisANT
(http://visant.bu.edu) (Hu et al., 2004).
Hypergeometric distribution was used to evaluate the overrepre-
sentation of NBIA and iron-related gene transcripts in the gene co-
expression modules (nominal p-values b0.05 were considered sig-
niﬁcant). To further assess the statistical signiﬁcance of the enrich-
ment of NBIA genes in given putamen modules, we developed a
permutation test to estimate the probability that g genes will be
found together by chance within a module of size equal or less
than m for a given partition of genes G = {g1,…, gn}, arranged into
k modules P = {p1,…,pk}, such that each gene gi belongs only to a
single module. To estimate the probability of ﬁnding g genes in a
module of size m or less in partition P, we randomly permuted the
genes in G in a list and annotated each gene in that list with the
module in P to which the gene belongs. Then we repeated the fol-
lowing procedure 106 times, randomly choosing g positions from
the list and checking whether the corresponding genes were anno-
tated with the same module and the module had size m or less. Fi-
nally, the probability of ﬁnding by chance g genes in a module of
size m or less was estimated by dividing by 106 the number of
times g genes were found together in such modules.
2.3. Validation of basal ganglia co-expression networks in independent
data sets
We used independent and publicly available basal ganglia gene
expression networks (Oldham et al., 2008), from 27 adult caudate nu-
cleus samples, to investigate whether our NBIA-containing modules
overlap with modules in those previously published networks. We
also used the only publicly available basal ganglia pediatric whole-
transcriptome gene expression data set (Kang et al., 2011) (7 striatum
samples from clinically unremarkable donors with ages ranging from
2 to 19 years) to perform WGCNA (Langfelder and Horvath, 2008;
Zhang and Horvath, 2005). We generated pediatric signed networks
using a power (Beta) of 33 and a height of 0.2. A total of 15,285 genes
passing quality control were used to identify modules. Fisher's exact
test was used to determine the signiﬁcance of the overlap between dis-
tinct networks (nominal p b 0.05 was considered signiﬁcant).
2.4. Gene expression analysis in NBIA diseased basal ganglia tissue
Additional validation studies investigated whether the NBIA-
containing modules overlap with differentially expressed genes in
human NBIA disorders. We used post-mortem basal ganglia tissue
from two adults, onemale and one female (66 and 81 years at death, re-
spectively), with a conﬁrmed clinicopathological diagnosis of NBIA
(Canadian Brain Tissue Bank, University of Toronto, Canada), and two
age- and gender-matched adults with no diagnosed neurological condi-
tions (Newcastle Brain Tissue Resource, University of Newcastle, UK).
All brain tissue was obtained with fully informed consent and the
study was approved by the Human Research Ethics Committee of the
University of Newcastle, Australia (H-2010-1219). Total RNA was ob-
tained as previously described (Johnstone et al., 2012; Acikyol et al.,
2013), and arrays performed using the Illumina HumanHT-12 v4 Ex-
pression BeadChip (Illumina, San Diego, USA). Following Cubic Spline
normalization in GenomeStudio Gene Expression Module (Illumina,
v2010.3), genes were considered differentially expressed if the fold-
change of the mean NBIA signal relative to the mean control signal for
Table 1
Neurodegeneration with brain iron accumulation disorders.
Disease Gene OMIM Inheritance Disease onset MRI changes Neuropathologic ﬁndings in
humans
Iron deposition White Matter changes Other ﬁndings
Aceruloplasminemia (ACP) CP 117700 AR Adulthood Globus pallidus, putamen,
caudate, thalamus, red and
dentate nuclei
Moderate, severe Mild cerebellar atrophy Globular deposits (grumose or
foamy spheroid bodies) in
astrocytes N neurons
Neuroferritinopathy (FTL) FTL 134790 AD Adolescence to adulthood Globus pallidus, putamen,
caudate, red and dentate
nuclei, thalamus
Mild, moderate Cystic cavitation/necrosis
in basal ganglia, mild
cerebral, cerebellar atrophy
Distorted, iron-laden nuclei
Pantothenate kinase-associated
neurodegeneration (PKAN)
PANK2 606157 AR Typically childhood Globus pallidus, substantia
nigra (mild)
None reported “Eye-of-the-tiger” sign neuroﬁbrillary tangles, spheroids
COASY protein-associated
neurodegeneration (CoPAN)
COASY 609855 AR Childhood Globus pallidusa,
substantia nigraa
NA “Eye-of-the-tiger” sign NA
PLA2G6-associated
neurodegeneration (PLAN)
PLA2G6 603604 AR Childhood to adulthood Globus pallidus, substantia
nigraa
Mild Moderate cerebral and
cerebellar atrophy
Lewy bodies, neuroﬁbrillary
tangles, spheroids
Mitochondrial membrane
protein-associated
neurodegeneration (MPAN)
C19orf12 614297 AR Typically childhood Globus pallidus, substantia
nigra
NA Myelin deﬁcit on
pyramidal tracts and optic
nervea
Lewy bodies, spheroids,
hyperphosphorylated tau
inclusions
Fatty acid hydroxylase-associated
neurodegeneration (FAHN)
FA2H 611026 AR Typically childhood Globus pallidus, substantia
nigraa
Moderate Pontocerebellar atrophy,
thin corpus callosum
NA
Kufor-Rakeb syndrome (KRS) ATP13A2 610513 AR Adolescence Globus pallidusa,
putamena, caudatea
NA Severe cerebral, cerebellar,
brain stem atrophy
NA
Beta-propeller protein-associated
neurodegeneration (BPAN)
WDR45 300526 XLD Adolescence to adulthood Globus pallidusa,
substantia nigraa
Mild Mild cerebellar atrophy NA
Woodhouse-Sakati syndrome
(WSS)
DCAF17 (C2orf37) 612515 AR Adolescence to adulthood Globus pallidusa Moderate to severe, conﬂuent NA NA
NA — no information available.
a Inconsistent ﬁndings or very small number of cases.
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62 C. Bettencourt et al. / Neurobiology of Disease 87 (2016) 59–68each brain region was at least 1.5. The small sample size prevented sta-
tistical comparison ofmeans and further analysis. Chi-square testingde-
termined the signiﬁcance (nominal p b 0.05) of the overlap between
differentially expressed genes in NBIA brain and NBIA-enriched co-
expression modules in normal human brain.
2.5. Gene expression analysis in Hfe−/−xTfr2mutAKR mice brains
The Hfe−/−xTfr2mut mouse model of iron overload was generated
previously (Delima et al., 2012) by crossing mice with deletion of the
Hfe gene (Hfe−/−) (Johnstone et al., 2012; Zhou et al., 1998; Fleming
et al., 2001; Trinder et al., 2002) with mice harboring the p.Y245X non-
sense mutation in the transferrin receptor 2 gene (Tfr2mut) (Acikyol
et al., 2013; Fleming et al., 2002; Drake et al., 2007; Chua et al., 2010).
Mice were on an AKR genetic background, which manifests a strong
iron loading phenotype (Fleming et al., 2001; McLachlan et al., 2011).
Further details of the Hfe−/−xTfr2mut model are provided elsewhere
(Delima et al., 2012).
All protocols were approved by the Animal Ethics Committees of the
University of Western Australia. Male wild-type and Hfe−/−xTfr2mut
mice were fed standard mouse chow from weaning. At 10 weeks of
age, Hfe−/−xTfr2mut mice were switched to an iron-supplemented diet
containing 2% carbonyl iron (Sigma Aldrich, St. Louis, MO, USA) for 3
weeks. At 13weeks of age,micewere anesthetized (50mg/kg ketamine,
10 mg/kg xylazine; Troy Laboratories Pty Ltd., Smithﬁeld, NSW,
Australia) and perfused transcardially with isotonic saline. Brain tissue
was collected and snap frozen in liquid nitrogen.
RNA isolation and microarray analysis were performed as described
in the previous section except that samples (n= 4 per group) were hy-
bridized to Illumina Sentrix MouseRef-8 v2.0 BeadChip microarrays, as
previously described (Johnstone et al., 2012; Acikyol et al., 2013). Mi-
croarray data were subjected to Average or Cubic Spline normalization
in GenomeStudio Gene Expression Module (Illumina, v2010.3) and dif-
ferential expression determined using either GenomeStudio (error
model Illumina Custom) or GeneSpring GX 7.3 (Agilent Technologies,
Santa Clara, CA, USA) as described elsewhere (Johnstone et al., 2012),
generating four lists of differentially-expressed genes. Analyses consid-
ered both the union of these four lists (i.e. genes calculated as differen-
tially expressed by at least one of the above mentioned methods) to
minimize false negatives, and the intersection (i.e. genes calculated as
differentially expressed by all four of the above mentioned methods)
to minimize false positives, as detailed elsewhere (Johnstone et al.,
2013). A subset of differentially expressed genes was selected for fur-
ther investigation in additional biological replicates (n = 7 per group)
using real-time RT-PCR (further details are available upon request).
2.6. Functional annotations and enrichment analysis
To evaluate the biological and functional relevance of NBIA gene
expression networks g:Proﬁler (http://biit.cs.ut.ee/gproﬁler/) (Reimand
et al., 2007, 2011) was used. Only genes present in the adult brain net-
works were used as background for this analysis. Overrepresentation of
Gene Ontology (GO) categories, KEGG pathways, and Human Phenotype
Ontology (HPO) terms was examined. The g:SCS algorithm was used to
account for multiple testing correction, and corrected p b 0.05 was
considered signiﬁcant.
3. Results
3.1. Regional expression of NBIA genes correlates with the likelihood of
white matter involvement
Our data and data from the Human Brain Transcriptome project
(http://hbatlas.org) (Kang et al., 2011; Johnson et al., 2009) show that
NBIA genes are highly expressed in the human brain throughout devel-
opment and aging. Analysis of 10 brain regions demonstrates that thebasal ganglia (putamen and substantia nigra herein studied) are usually
not among the regionswith the highest expression levels of NBIA genes
(Fig. 1). Strikingly, NBIA genes typically associated with white matter
changes (Table 1) exhibit the highest expression levels in the white
matter (FTL, FA2H, DCAF17, CP, and PLA2G6), while those not associated
with white matter involvement (e.g. PANK2) exhibit their lowest levels
in this region (Fig. 1), suggesting a relationship between the pattern of
gene expression and the observed pathology.
3.2. Gene co-expression network analysis identiﬁes basal ganglia
NBIA-enriched modules
To better understand the functional relationship between NBIA
genes, we applied WGCNA to whole-transcriptome data, and focused
on basal ganglia modules (Table 2). The substantia nigra shows no sig-
niﬁcant clustering of NBIA genes. The putamen, however, shows the
highest clustering in all 10 brain regions analyzed, consistent with clin-
icopathological features found in NBIAs converging on basal ganglia in-
volvement. Only 4/20 putamen gene co-expression modules contain
NBIA transcripts (Table 2), with a statistically signiﬁcant clustering in
the brown (PANK2, ATP13A2, C19orf12, and COASY; hypergeometric
distribution p = 0.003; permutation test p = 1.99 × 10−4) and green
(FTL, DCAF17, and FA2H; hypergeometric distribution p = 0.021; per-
mutation test p= 2.19 × 10−4) modules. Fig. 2 shows interconnections
of genes within these NBIA-enriched modules. All putamen NBIA-
containing modules are well preserved across all 10 brain regions (Z
summary scores N 10) (Langfelder et al., 2011), which is in line with
the clinicopathological complexity of NBIA disorders involving other
brain regions (Schneider et al., 2013; Levi and Finazzi, 2014; Hogarth,
2015; Kruer, 2013).
The putamen alongwith the caudate nucleus forms the striatum, the
primary recipient of inputs to the basal ganglia system (Delgado, 2007).
To validate our networks, we determinedwhether our NBIA-containing
modules are composed of the same genes as those in publicly available
caudate nucleus networks (Oldham et al., 2008) and identiﬁed a highly
signiﬁcant overlap between these two basal ganglia networks (e.g. our
brown module vs their M16C module: p = 1.38 × 10−22; our green
module vs their M9C module: p = 2.69 × 10−166). Furthermore, as
NBIA disorders often have a childhood onset, we constructed pediatric
gene co-expression networks. The greatest overlap between the adult
NBIA-enriched brown and green modules, and the pediatric striatum
modules occurs with the striatum aliceblue (p = 2.69 × 10−45) and
lightyellow (p = 4.52 × 10−80) modules, respectively. Five out of 10
NBIA genes cluster in the aliceblue module (p = 0.04), 3 of which
(ATP13A2, COASY, and PANK2) belong to the adult brown module.
3.3. Glial as well as neuronal cell types are implicated in basal ganglia NBIA
networks
Wenext askedwhether the putamenNBIA networks can provide in-
formation on speciﬁc cell types that may be involved in the origin of
NBIA disorders. A statistically signiﬁcant enrichment for neuronal
markers (Lein et al., 2007; Cahoy et al., 2008), including GRIN2B (99th
quantile) and SYT1 (83rd quantile), was found in the putamen brown
module (Table 3). GAD2 gene (83rd quantile), a marker for GABAergic
neurons (Kodama et al., 2012), is also present. Conversely, an overrep-
resentation of oligodendrocyte markers (Lein et al., 2007; Cahoy et al.,
2008), including MAG (98th quantile), MOG (96th quantile), and
OLIG2 (57th quantile), was found in the putamen green module. This
module contains the NBIA gene FA2H (84th quantile), also previously
described as an oligodendrocyte-enriched gene (Lein et al., 2007;
Cahoy et al., 2008). The other two NBIA-containing modules, including
the one with CP, resemble astrocytic signatures. Overlapping modules
from the caudate nucleus networks are reported by Oldham et al.
(Oldham et al., 2008) to be enriched for the same cell types. The pediatric
striatum aliceblue (containing 5 NBIA genes) and burlywood (containing
Fig. 1. Expression patterns of NBIA genes in pathologically conﬁrmed normal human brains. The following brain regions were studied: cerebellum (CRBL), frontal cortex
(FCTX), hippocampus (HIPP), medulla (MEDU), occipital cortex (OCTX), putamen (PUTM), substantia nigra (SNIG), temporal cortex (TCTX), thalamus (THAL), and white
matter (WHMT, highlighted in red). A) Example of brain expression patterns of an NBIA gene (FA2H) which presents the highest expression levels in the white matter.
B) Example of brain expression patterns of an NBIA gene (PANK2) which presents the lowest expression levels in the white matter.
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(Table 3), respectively.
We further investigated expression patterns of NBIA genes using
mouse brain data from the Allen Brain Atlas (http://mouse.brain-map.
org) (Lein et al., 2007). NBIA genes in the brownmodule seem to differ-
entiate gray from white matter and behave similarly to the neuronal
markers (Fig. 3), while genes in the green module behave similarly to
oligodendrocytic markers. This is also in agreement with the relatively
higher expression of green module genes in the white matter.
3.4. Basal ganglia NBIA gene networks implicate synapse and lipid
metabolism
In line with the cell types described above, in the putamen brown
module, which includes PANK2, ATP13A2, C19orf12, and COASY, several
GO terms related with synaptic transmission, neuron projection devel-
opment, protein modiﬁcation by small protein conjugation or removal,
modiﬁcation-dependent protein catabolic process, and synapse are
overrepresented. Synaptic vesicle cycle KEGG pathway (KEGG:04721)
is also enriched (p=2.33 × 10−4).We further investigated thismodule
for the presence of genes encoding for well-known synaptic vesicle andTable 2
NBIA genes/transcripts assigned to basal ganglia gene co-expression modules.
NBIA gene Affy transcript ID Putamen
Module (size)
PANK2 3874533 Brown (1696)
COASY 3721851
ATP13A2 2398736
C19orf12 3857808
3857811
FTL 3838094 Green (950)
DCAF17 2515183
FA2H 3699133
CP 2700244 Greenyellow (171)
PLA2G6 3960388 Turquoise (6888)
WDR45 4007774
Size — number of genes in the module; Quantile — quantile for module membership.
Module memberships above the median are highlighted in bold.synaptic plasma membrane proteins (Morciano et al., 2005). Synaptic
vesicle genes VAMP2, SYT1, and RAB3A have high module memberships
in the brown module, as do pre- and post-synaptic plasma membrane
genes, including SNAP25, ATP1A3, DLG2, DLG3, and DLG4 (all N75th
quantile).
For the green module, which includes FTL, DCAF17, and FA2H, enrich-
ment analysis shows a signiﬁcant overrepresentation of multiple GO
terms, such as ensheathment of neurons, lipid biosynthetic process,mem-
brane organization, myelin sheath, dipeptidase activity, and protein bind-
ing. The Sphingolipid metabolism KEGG pathway (KEGG:00600), which
is essential for proper myelination, is also overrepresented (p =
1.15 × 10−2). We observed that our NBIA-containing modules comprise
at least 21/29 myelination-related genes (as deﬁned by (Hakak et al.,
2001)), and the green module alone contains 12, includingMAG, MOG,
PLP1, and CNP (all N95th quantile).
3.5. Basal ganglia NBIA gene networks tightly link to iron metabolism
As the unifying feature in NBIA disorders is focal basal ganglia iron
accumulation, we investigated whether iron metabolism-related genes
(Rouault, 2013; Constantine et al., 2008) are present in the putamenSubstantia Nigra
Quantile Module (size) Quantile
56 Brown (1696) 88
25 54
54 Yellow (1902) 90
57 13
30 55
24 Purple (401) 64
37 Red (1099) 63
84 Green (1483) 92
35 Red (900) 42
19 Green (1437) 37
80 Turquoise (4109) 87
Fig. 2.Network representation of theputamenNBIA-enrichedmodules generatedusingVisANT (http://visant.bu.edu) (Huet al., 2004). A) Brownmodule, showinggenes connectedwith a
topological overlapmeasure (TOM) N 0.08. B)Greenmodule, showinggenes connectedwith a TOM N 0.18.NBIA genes are highlighted in red and iron-relatedgenes are inpurple. Given the
TOM cut-offs used, not all NBIA and iron-related genes could be included. The biggest circles represent the top hub genes in eachmodule, which stands for themost interconnected genes
in the module. Note the connections of NBIA genes and iron-related genes with the same hub genes.
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responsive element binding protein 2 gene (IREB2), a key gene in the reg-
ulation of intracellular iron homeostasis. It also includes SLC25A37, which
encodes for the mitochondrial iron importer mitoferrin 1, as well as
EXOC6 (exocyst complex component 6, which is linked to the transferrin
cycle (Lim et al., 2005), hub gene – 91st quantile),HMOX2 (heme oxygen-
ase), and PGRMC1 (heme binding protein). The greenmodule, apart from
the NBIA FTL gene, also includes the ferritin heavy polypeptide 1 (FTH1),
which are both important for iron sequestration. Additionally, it contains
transferrin (TF, hub gene–98thquantile), transferrin receptor (TFRC), and
solute carrier family 11member 2 (SLC11A2 also known asDMT1, proton-
coupled divalentmetal ion transporter) genes, all involved in iron uptake.
An overrepresentation of key iron-related genes is observed in these
two gene expression modules (12/36 transcripts, p = 0.007),Table 3
Basal ganglia NBIA-containing modules are enriched for cell-speciﬁc markers.
Network NBIA-containing modules Oligodend
Adult putamen
Brown 176/1537
Green
303/1537
(p = 5.94
Greenyellow 10/1537
Turquoise 289/1537
Pediatric striatum
Aliceblue 263/1384
Bisque3 205/1384
Burlywood
26/1384
(p = 1.21
Darkolivegreen1 243/1384
Green4 17/1384
Lightpink3 22/1384
Enrichment analysis for Oligodendrocytes, Astrocytes and Neurons-enriched genes in NBIA-c
maximum possible overlapping genes. Signiﬁcance was evaluated using Fisher's exact test (on
Statistically signiﬁcant enrichments for speciﬁc cell types are highlighted in bold.
a Genes enriched in major cell types as deﬁned by Cahoy et al. (2008).suggesting that they play a central role in brain iron metabolism. NBIA
genes and iron-related genes are interconnected with the same hub
genes (Fig. 2), suggesting that perturbations of these networks may un-
derlie the iron metabolism dysregulation seen in NBIA disorders. We ob-
served a signiﬁcant overlap between genes differentially expressed in
post-mortem basal ganglia tissue of NBIA cases compared to matched
controls and genes in the green (p b 0.0001) and brown (p=0.04)mod-
ules, suggesting that these networks are indeed disturbed in NBIA brains.
3.6. Excessive brain iron loading disturbs basal ganglia NBIA gene networks
To investigate whether the accumulation of iron itself triggers
disturbances in NBIA networks, we investigated gene expression
changes in an iron overload mouse model (Hfe−/−xTfr2mut) withoutrocytesa Astrocytesa Neuronsa
128/1878
375/1445
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ontaining modules. Fractions represent the number of overlapping genes relative to the
ly p-values b 0.05 are shown).
Fig. 3. Expression patterns of NBIA genes and neuronal or oligodendrocyte markers (A–C), using data from the Allen Brain Atlas (http://mouse.brain-map.org) (Lein et al., 2007), and
patterns of iron accumulation in the brain of wild-type and Hfe−/−xTfr2mut mice (D). A) Genes in the neuronal-enriched module (putamen brown module, 1600014C10Rik is the
mouse ortholog for C19orf12); B) Genes in the oligodendrocyte-enrichedmodule (putamen greenmodule, data for FTLwas not available); C) NBIA genes in other co-expressionmodules;
D) 3,3′-diaminobenzidine-4HCl (DAB)-enhanced Perls' staining shows iron loading in the caudate-putamen and corpus callosum of the Hfe−/−xTfr2mut mice compared with matched
wild-type mice. CC— corpus callosum; CP— caudate-putamen.
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(Fig. 3) and ferritin levels (N1.7-fold, p b 0.025) at 12 weeks of age. In
both mutant and wild-type mice brains, iron levels increase with age,
and iron localizes predominantly in the basal ganglia and the choroid
plexus, and overlaps with myelin-rich areas. At age 13 weeks, brain
gene expression analysis in male mice reveals differentially expressed
genes in the mutants when compared to wild-type (310 upregulated
and 451 dowregulated genes, p b 0.05). Themutantmice showdownreg-
ulation of ﬁve NBIA genes (orthologues for PLA2G6, FA2H, CP, C19orf12,
and ATP13A2) (Heidari et al., 2014), and there is excessive overlap
between genes in the human NBIA-enriched modules (both green and
brown) and genes differentially expressed (mostly downregulated) in
the mutant compared to wild-type mice (p b 1.00 × 10−4). Many ofthese genes are highly interconnected within the NBIA networks (hub
genes, N90th quantile), including for example CNP (a myelin-related
gene) from the green module, and ATP6V0A1 (synaptic vesicle-related
gene) from the brown module. This suggests that increased brain iron
load disturbs the NBIA networks.
Functional enrichment analysis for dysregulated genes in themutant
mice overlapping with green or brown module genes reveals an over-
representation of GO terms related with the endomembrane system.
Phagosome (KEGG:04,145, p = 3.52 × 10−2) and Synaptic vesicle
cycle (KEGG:04,721, p = 3.94 × 10−2) pathways are also enriched for
genes overlapping with the green and brown modules, respectively.
Overall, brain iron overload seems to compromise membrane trafﬁck-
ing by disrupting basal ganglia NBIA gene networks.
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We further investigated whether genes in our basal ganglia NBIA
networks are associated with additional human neurological disorders
with abnormal brain iron content (Dusek et al., 2012; Sipe et al., 2002;
Oshiro et al., 2011; Batista-Nascimento et al., 2012). This is the case
for genes associated with Mucolipidosis type IV (MCOLN1-OMIM#
605248), X-linked sideroblastic anemia with ataxia (ABCB7-
OMIM#300135), Parkinson's disease (VPS35-OMIM#601501, and
SYNJ1-OMIM#604297), Alzheimer's disease (ADAM10-OMIM#602192,
and PLD3-OMIM#615698), and amyotrophic lateral sclerosis (UBQLN2-
OMIM#300264, VCP-OMIM#601023, SIGMAR1-OMIM#601978, and
SOD1-OMIM#147450). Furthermore, as a proof of principle that these
networks provide pools of candidate genes, there are recent reports on
NBIA compatible phenotypes associated with mutations in RAB39B
(OMIM#300774) (Wilson et al., 2014) and UBQLN2 (OMIM#300264)
(Fahed et al., 2014) – two genes belonging to our NBIA-enriched
networks.
We also explored Human Phenotype Ontology (HPO) terms asso-
ciated with the 10 NBIA genes and inferred whether other genes in
our networks are associated with the same HPO terms. In the top 15
most signiﬁcantly enriched terms for NBIAs are core NBIA symptoms,
such as Dystonia (HP:0001332, p = 6.79 × 10−19), Dysarthria
(HP:0001260, p = 1.23 × 10−11), Cognitive impairment
(HP:0100543, p = 1.87 × 10−11), Parkinsonism (HP:0001300, p =
1.01 × 10−10), and Spasticity (HP:0001257, p = 1.96 × 10−10). Crossing
our putamen NBIA-enriched modules with genes associated with at
least two of those core HPO terms and an OMIM entry, we found
genes associated with Parkinson's disease (SYNJ1-OMIM#604297),
spastic paraplegia (BSCL2-OMIM#606158), Lesch-Nyhan syndrome
(HPRT1-OMIM#308000), and other neurological diseases/syndromes
(ATP6AP2-OMIM#300556, L1CAM-OMIM#308840), among highly in-
terconnected genes (≥95th quantile) of the brown module. In the top 5
quantiles of the green module, we found genes associated with spastic
paraplegia (PLP1-OMIM#300401), Niemann-Pick disease (NPC1-
OMIM#607623), and Canavan disease (ASPA-OMIM#271900).
4. Discussion
NBIA disorders share a core set of clinicopathological features,
including neurodegeneration, but not much is known about the
originating cell type. According to our data and in line with NBIA
histopathological features, multiple cell types are likely to be in-
volved. Neuronally-derived eosinophilic spheroid bodies, thought
to represent degenerating neurons and accumulation of protein
and lipid storage material as well as damaged organelles (e.g. mito-
chondria and vesicles), are a pathologic hallmark of several NBIA
disorders, including those caused by mutations in PANK2 and
C19orf12 (Kruer, 2013) — genes that belong to a co-expression mod-
ule that reﬂects neuronal signatures. Myelin loss has been associat-
ed with FTL mutations (Kruer, 2013) and FA2H deﬁciency (Zoller
et al., 2008; Potter et al., 2011) — genes of a module that reﬂects
oligodendrocytic signatures and is associated with myelination. In-
deed, factors involved in myelination, namely FA2H, are gaining rel-
evance in brain disease (e.g. autism spectrum disorders Scheid et al.,
2013). Enlarged and distorted iron-overloaded astrocytes (Kruer,
2013) are a core pathological feature in NBIA patients with CPmuta-
tions, and this gene is in an astrocytic-like module. This multitude of
cellular origins suggests that neuronal death in NBIA disorders can
result from direct insults to neurons or as secondary events caused
by the loss of support normally provided by astrocytes and/or
oligodendrocytes.
Dysfunction of membrane trafﬁcking is a hallmark of many neuro-
logical and psychiatric diseases (Wang et al., 2013; Kitagishi et al.,
2015), with a decreased degradation capacity of pre- and post-
synaptic trafﬁcking compartments leading to the accumulation ofdysfunctional intracellular machineries (Wang et al., 2013). Our data
shows the involvement of the synapse and the endomembrane system
in the NBIA networks. It is possible that the characteristic NBIA spheroids
are a reﬂection of these events, with consequent neurodegeneration due
to the inherent toxicity of the cargo overload or a toxic cellular response
to such overload (Wang et al., 2013). NBIAs share the variable accu-
mulation of α-synuclein-positive Lewy bodies and/or tau pathology
and brain iron deposition with common neurodegenerative diseases
(e.g. Parkinson's and Alzheimer's diseases (Kruer, 2013)). A better
understanding of the synaptic pathology in NBIAs raises the hope
for the development of therapeutic strategies that will improve syn-
aptic maintenance, which is essential for neuronal health, and help
to therapeutically tackle NBIAs and more common neurological,
psychiatric and neurodevelopmental diseases sharing underlying
pathology.
Iron is essential for normal neurological function, as it is required for
the production of high levels of ATP needed to maintain membrane
ionic gradients, synaptic transmission, axonal transport, neurotransmit-
ter synthesis, myelination, etc (Piñero and Connor, 2000). The brain
tends to accumulate ironwith age, and the globus palllidus, red nucleus,
substantia nigra, and caudate-putamen have higher concentrations of
iron throughout life (Piñero and Connor, 2000). Pronounced and pre-
mature iron accumulation in the basal ganglia is a hallmark of NBIA dis-
orders, which probably involves loss of concordant regulation between
iron uptake, storage and transport within the brain.
Only twoNBIA genes (FTL and CP) have been so far directly implicat-
ed in iron metabolism. While mutations in FTL disrupt the structure of
ferritin and modify its capacity to incorporate iron (Luscieti et al.,
2010), mutations in CP lead to defective export of iron from cells (di
Patti et al., 2009). We showed important connections of iron-related
genes within the basal ganglia NBIA networks, indicating a broader in-
volvement of NBIA genes in iron-related processes. Deﬁciency of the
IREB2, a gene present in our networks and a key regulator of intracellu-
lar iron homeostasis (Rouault, 2013), is enough to cause progressive
neurodegeneration with prominent caudate-putamen iron accumula-
tion in mice (LaVaute et al., 2001). Genes involved in iron uptake (TF,
TFRC, and DMT1) and storage (FTL and FTH1) are present as well. There-
fore, disruptions in these networks (e.g. by mutations in NBIA genes)
likely dysregulate iron-related processes.
We have also shown that brain iron overload can be associated with
dysregulated expression of genes present in the NBIA networks, in-
cluding downregulation of several NBIA genes, even in the absence of
mutations in NBIA genes. Altogether, this raises the hypothesis that dis-
turbances in NBIA gene networks contribute to dysregulation of iron
metabolism and, in turn, progressive increase in brain iron levels (e.g.
with aging) aggravates the disruption of these gene networks. Accord-
ing to this hypothesis, iron accumulation is not mandatory for the
onset of the symptoms, but it seems essential in determining the fate
of disease progression. This is consistent with the fact that not all pa-
tients with mutations in NBIA genes show signiﬁcant brain iron over-
load in early stages of the disease (Johnstone et al., 2013; Potter et al.,
2011). Whether this ﬁnding merely reﬂects the incapacity of MRI
methods to detect subtle iron level changes remains debatable. A recent
report with promising results on the stabilization of the disease upon
treatmentwith an iron-chelating agent (Cossu et al., 2014) lends further
support to that hypothesis.
In conclusion, our human brain gene co-expression network analysis
suggests thatmultiple cell types act in the origin of the clinically hetero-
geneous group of NBIA disorders, and reveals strong links with iron-
related processes. Overall, our results show convergent pathways
connecting groups of NBIA genes and other neurological diseases
genes, providing possible points for therapeutic intervention. Given
the enrichment of these networks for genes associated with NBIA and
overlapping phenotypes, they provide reservoirs of candidate genes
useful for prioritizing genetic variants and boosting gene discovery in
ongoing collaborative sequencing initiatives.
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